Drugs & Therapy Perspectives

, Volume 10, Issue 4, pp 12–14 | Cite as

Gastric Toxicity: A Problem with Low-Dose Aspirin

Drug Reactions and Interactions


Chronic Obstructive Pulmonary Disease Aspirin Misoprostol Sucralfate Gastric Damage 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Low-dose aspirin beneficial in myocardial infarction. Drug Ther Perspect 1997; 10 (4): 6–8CrossRefGoogle Scholar
  2. 2.
    Guslandi M. Gastric toxicity of antiplatelet therapy with low-dose aspirin. Drugs 1997 Jan; 53 (1): 1–5PubMedCrossRefGoogle Scholar
  3. 3.
    Bochner F, Lloyd JV. Aspirin for myocardial infarction: clinical pharmacokinetic considerations. Clin Pharmacokinet 1995; 28 (6): 433–8PubMedCrossRefGoogle Scholar
  4. 4.
    Konturek JW, Dembinski A, Stoll R, et al. Mucosal adaptation to aspirin-induced gastric damage in humans: studies on blood flow, gastric mucosal growth and neutrophil activation. Gut 1994; 35: 1197–204PubMedCrossRefGoogle Scholar
  5. 5.
    Savon JJ, Allen ML, DiMarino AJ, et al. Gastrointestinal blood loss with low dose (325mg) plain and enteric-coated aspirin administration. Am J Gastroenterol 1995; 90: 581–5PubMedGoogle Scholar
  6. 6.
    Slattery J, Warlow CP, Shorrock CJ, et al. Risks of gastrointestinal bleeding during secondary prevention of vascular events with aspirin — analysis of gastrointestinal bleeding during the UK-TIA trial. Gut 1995; 37: 509–11PubMedCrossRefGoogle Scholar
  7. 7.
    Weil J, Colin-Jones D, Langman MJS, et al. Prophylactic aspirin and risk of peptic ulcer bleeding. Br Med J 1995; 310: 827–30CrossRefGoogle Scholar
  8. 8.
    Kaufman DW, Kelly JP, Sheehan JE, et al. Nonsteroidal anti-inflammatory drug use in relation to major upper gastrointestinal bleeding. Clin Pharmacol Ther 1993; 53: 485–94PubMedCrossRefGoogle Scholar
  9. 9.
    Lee M, Cruer B, Feldman M. Dose effects of aspirin and gastric prostaglandins and stomach mucosal injury. Ann Intern Med 1994; 120: 184–9PubMedGoogle Scholar
  10. 10.
    Lanza F, Peace K, Gustitus L, et al. A blinded endoscopic comparative study of misoprostol versus sucralfate and placebo in the prevention of aspirin-induced gastric and duodenal ulceration. Am J Gastroenterol 1988; 83: 143–6PubMedGoogle Scholar
  11. 11.
    Goddard AF, Donnelly MT, Filipowicz B, et al. Low-dose misoprostol as prophylaxis against low-dose aspirin-induced gastroduodenal mucosal injury [abstract]. Gut 1996; 39 Suppl. 1: A33Google Scholar
  12. 12.
    British National Formulary No. 33. London: The Pharmaceutical Press, 1997 Mar: 39Google Scholar

Copyright information

© Adis International LTD 1997

Personalised recommendations